European Commission Extends Deadline for Biocidal Substance Review to 2030

Challenges Leading to the Extension

The decision to extend the review program's timeline arises from several complex challenges encountered during the systematic examination process. Key issues identified by the Commission include:

• Resource Constraints: Member States have faced significant limitations in allocating sufficient resources to complete their assessment tasks under the program.
• Data Submission Delays: Applicants have been delayed in submitting necessary additional data, slowing down the review process.
• Technical and Regulatory Hurdles: The program has had to navigate complex technical questions, evolving technical guidance, and the introduction of new criteria for determining endocrine-disrupting properties, all of which have required additional time for thorough evaluation.

As of 1 October 2023, only 46% of the work program had been completed, indicating a clear need for an extended timeline to ensure all substances are properly reviewed.

Efforts to Address the Delays

In response to the delays, the Commission has taken a proactive approach to engage with relevant stakeholders and implement measures aimed at accelerating the review process. These efforts include:

• Stakeholder Engagement: Regular discussions with experts from Member States' authorities, ECHA, industry stakeholders, and civil society.
• Resource Enhancement Initiatives: Launching a grant initiative in 2023 to boost the capacities of Member States in evaluating and regulating biocides and pesticides.
• Action Plans and Workshops: Organizing workshops and adopting an ECHA action plan focused on active substances to streamline the review process.

Looking Forward

The extension to 2030 reflects the European Commission's commitment to conducting a thorough and meticulous review of biocidal substances, prioritizing human health and environmental safety. Furthermore, the Commission anticipates conducting a REFIT evaluation of the Biocidal Products Regulation, with potential legislative updates expected by the end of 2030.

During the recent public consultation, stakeholders expressed broad support for the extension, although some raised concerns regarding the new deadline's sufficiency and the need for adjustments to data protection provisions. The Commission has acknowledged these concerns and plans to review data protection legislation as part of its comprehensive evaluation of the regulatory framework governing biocidal products.